March 14, 2026
Life Science Magazines About Us Contact Us
Life Science Newswire Service™ (LS)
Submit a Press Release
  • Analytical chemistry
  • Business
  • Biomanufacturing & bioprocessing
  • Biotechnology
  • Diagnostics
  • Drug development
  • More News
    • Environmental Science
    • Food & beverage
    • Forensic science
    • Healthcare
    • Hospitals
    • Lab tools
    • Materials science
    • Microbiology
    • Nanotechnology
    • Pharma & Biopharma
    • Pharmacy
    • Veterinary
    • Water Management
  • Press Releases
Reading: Back to District Court? PTAB Strategic Recalibration in Patent Litigation
Share
Font ResizerAa
Life Science Newswire Service™ (LS)Life Science Newswire Service™ (LS)
Search
  • Business
  • Press Releases
  • Life Science Magazines
  • Life Sciences
    • Analytical chemistry
    • Biomanufacturing & bioprocessing
    • Biotechnology
    • Diagnostics
    • Drug development
    • Environmental Science
    • Food & beverage
    • Forensic science
    • Healthcare
    • Hospitals
    • Lab tools
    • Materials science
    • Microbiology
    • Nanotechnology
    • Pharma & Biopharma
    • Pharmacy
    • Veterinary
    • Water Management
  • About Us
  • Contact Us
  • Submit a Press Release
LS Newswire Service™ is part of GroupWeb Media Network. © 2025 GroupWeb Media LLC
Life Science Newswire Service™ (LS) > Blog > Life Sciences > Biotechnology > Back to District Court? PTAB Strategic Recalibration in Patent Litigation
Biotechnology

Back to District Court? PTAB Strategic Recalibration in Patent Litigation

By Newsroom
Last updated: February 22, 2026
1 Min Read
Share


For years, parallel proceedings at the Patent Trial and Appeal Board (PTAB) were the near-automatic response of a defendant in district court patent litigation. Accused infringers routinely filed petitions—especially inter partes review (IPR) petitions—challenging validity of the asserted patents at the PTAB. Given the PTAB’s technical expertise, historically favorable invalidation rates, and lower standard of review on invalidity, this has been a favored approach among defendants.

Today, that reflexive approach warrants reconsideration. Recent developments at the PTAB have prompted both patent owners and accused infringers to reassess…



Source link

Share This Article
Facebook Email Copy Link Print

HOT NEWS

Key Takeaways from CANECT 2025

Environmental Science
June 6, 2025

“الجهات الأربع” تؤكد جاهزيتها لضمان استمرارية سلاسل الإمداد الخاصة بعملائها في المنطقة

الرياض، المملكة العربية السعودية  — (ARAB NEWSWIRE) — أكدت شركة الجهات الأربع السعودية، المتخصصة في…

March 13, 2026

تُظهر الدراسة أن وجبة الإفطار الغنية بالجوز من الممكن أن تساعد في تعزيز قوة دماغك

California Walnut كما أظهر بحثٌ جديد أن تناول الجوز في وجبة الإفطار يمكن أن يحسّن…

April 5, 2025

Arab Newswire Provides Press Release Distribution in Arabic

Arab Newswire - Press release distribution to media in MENA/GCC Regions Newswire expands reach with…

April 5, 2025

YOU MAY ALSO LIKE

Updates on APEX-related Personal Jurisdiction Considerations Since SnapRays

Last year we discussed the implications of the Supreme Court’s choice not to review the Federal Circuit’s SnapRays decision for…

Biotechnology
February 8, 2026

Further Shifts in Patent Office Guidance for Discretionary Denials Signal Uphill Battles for Patent Challengers

On the heels of the rescission of the Fintiv guidance memorandum, the U.S. Patent and Trademark Office has again reshaped…

Biotechnology
April 5, 2025

Federal Circuit Vacates $300 Million Verdict Against Apple, Orders Third Trial in LTE Patent Dispute

In a pivotal ruling for patent damages and standard-essential patent (SEP) litigation, the Federal Circuit vacated a $300 million award…

Biotechnology
July 11, 2025

Federal March-In Rights Meet Clawbacks – The Future of 35 USC ss. 200-212 |

This post could have been “The Revival of the March-In Rights of the Bayh-Dole Act.” The passage of the Bayh-Dole…

Biotechnology
April 26, 2025
Life Science Newswire Service™ (LS)

Contact Us

  • Whatsapp: +1 832-716-2363
  • Skype: Groupwebmedia
  • Telegram: Groupwebmedia

Share Us

About Us

Life Science Newswire Services (LS)™ aggregates, publishes and distributed news about the Life Science industry. In association with EmailWire, LS provides press release distribution services in the Life Science sector. Press releases are disseminated to journalists, experts, investors, trade publications and other related media outlets. For more information, contact us.

Categories

Analytical chemistry
Business
Biomanufacturing & bioprocessing
Biotechnology
Diagnostics
Drug development
Environmental Science
Food & beverage
Forensic science
Healthcare
Hospitals
Lab tools
Materials science
Microbiology
Nanotechnology
Pharma & Biopharma
Pharmacy
Veterinary
Water Management
Life Science Magazines
Press Releases

Recent News

“الجهات الأربع” تؤكد جاهزيتها لضمان استمرارية سلاسل الإمداد الخاصة بعملائها في المنطقة
March 13, 2026
Four Winds Saudi Arabia Strengthens Supply Chain Continuity Across the GCC with Flexible Logistics Solutions
March 13, 2026
Erectile Dysfunction Drugs Market size to Reach USD 7.15 Billion by 2031 as Telemedicine Expansion and OTC Access Influence Market Trends
March 13, 2026
Metaverse in Healthcare Market size to Reach USD 62.36 Billion by 2031 as Virtual Care Platforms and Immersive Training Shape Market Trends
March 13, 2026

Life Science Magazines

Is Your Site Strategy Ready for FDA's Access Push?
March 12, 2026
Everything You Need To Know About NGS
March 12, 2026
Clinical Supply Chain Therapy: Lowering Risk (And Your Blood…
March 11, 2026
Enabling data-driven decision making for drug development…
March 10, 2026

LS Newswire Service™ is part of GroupWeb Media Network. © 2026 GroupWeb Media LLC

Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?